GlomCon(@GlomCon) 's Twitter Profile Photo

self-promotion 🤫

A GlomCon Real-World Evidence Study

The Natural History of Focal and Segmental Glomerulosclerosis (FSGS)

A large-scale, multi-center, RWE study of patients in diverse healthcare settings with a tissue diagnosis of FSGS

asn-online.org/education/kidn…

#KidneyWk self-promotion 🤫

A GlomCon Real-World Evidence Study

The Natural History of Focal and Segmental Glomerulosclerosis (FSGS)

A large-scale, multi-center, RWE study of patients in diverse healthcare settings with a tissue diagnosis of FSGS

asn-online.org/education/kidn…
account_circle
GlomCon(@GlomCon) 's Twitter Profile Photo

pearls continues:

Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Focal Segmental Glomerulosclerosis (FSGS): Results from the Phase 3 DUPLEX Trial

Presented by no one less than Michelle Rheault
Watch here
youtu.be/-q93K8lbk9Q?si…

#KidneyWk pearls continues:

Sparsentan (SPAR) vs. Irbesartan (IRB) in Patients with Focal Segmental Glomerulosclerosis (FSGS): Results from the Phase 3 DUPLEX Trial

Presented by no one less than @rheault_m 
Watch here  
youtu.be/-q93K8lbk9Q?si…
account_circle
Cristina Popa(@NephroSeeker) 's Twitter Profile Photo

Cristina Popa, here! 👋 Just a general nephrologist wanting to learn more about kidney transplant! Here or pod 1 🔥

Trying to adapt my schedule back to my timezone after , but when cannot sleep anyway

Pic from the park across my hospital 2 days ago 🎨✍️

Cristina Popa, here! 👋 Just a general nephrologist wanting to learn more about kidney transplant! Here or pod 1 #NSMC 🔥

Trying to adapt my schedule back to my timezone after #Kidneywk, but when #NephJC cannot sleep anyway

Pic from the park across my hospital 2 days ago 🎨✍️
account_circle
GlomCon(@GlomCon) 's Twitter Profile Photo

pearls continued 👇

Lots of discussion around SGLT2i in IGAN.
Isabelle Ayoub and Brad H Rovin provided a sneak preview of the PROTECT Open-Label Extension and SPARTACUS studies

Spoiler alert 🚨 well tolerated + additional proteinuria reduction. More to come

#KidneyWk pearls continued 👇

Lots of discussion around SGLT2i in IGAN. 
@AyoubIsabelle and @BradRovin provided a sneak preview of the PROTECT Open-Label Extension and SPARTACUS studies 

Spoiler alert 🚨 well tolerated + additional proteinuria reduction. More to come
account_circle
GlomCon(@GlomCon) 's Twitter Profile Photo

GN pearl:

ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population

Median time to ESKD: 2.6 years
After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯

asn-online.org/education/kidn…

#KidneyWk GN pearl:

ESKD and CKD Progression Among a Diverse Immunoglobulin A Nephropathy (IgAN) Population

Median time to ESKD: 2.6 years
After 20 yrs, probability of >40% GFR decline or ESKD ~70% 🤯

asn-online.org/education/kidn…
account_circle
GlomCon(@GlomCon) 's Twitter Profile Photo

pearl

An interesting report by Sinead Stoneman and colleagues on ANCA-negative pauci-immune glomerulonephritis

What explains the worse kidney function at the time of diagnosis - delay in diagnosis or more aggressive disease?
asn-online.org/education/kidn…

#KidneyWk pearl

An interesting report by @Stones__  and colleagues on ANCA-negative pauci-immune glomerulonephritis

What explains the worse kidney function at the time of diagnosis - delay in diagnosis or more aggressive disease?
asn-online.org/education/kidn…
account_circle
Sandra Herrmann MD, FASN(@HerrmannMd) 's Twitter Profile Photo

Wrapping up the 2023! It was great to see many colleagues and friends! But unfortunately some couldn’t make it and others had a busy schedule. Looking forward already to next year American Society of Nephrology . Can’t tag everyone…

Wrapping up the  #KidneyWk  2023! It was great to see many colleagues and friends! But unfortunately some couldn’t make it and others had a busy schedule. Looking forward already to next year #KidneyWk  @ASNKidney . Can’t tag everyone…
account_circle
GlomCon(@GlomCon) 's Twitter Profile Photo

GN pearl of the day:

Corticosteroid Dose and Risk of Infection in Children and Adults with Glomerular Disease: An Analysis of the CureGN Study

Highlighting the importance of steroid-sparing regimens (?also infection prophylaxis?)
asn-online.org/education/kidn…

#KidneyWk GN pearl of the day:

Corticosteroid Dose and Risk of Infection in Children and Adults with Glomerular Disease: An Analysis of the @CureGn Study

Highlighting the importance of steroid-sparing regimens (?also infection prophylaxis?) 
asn-online.org/education/kidn…
account_circle
Arohan Subramanya(@arohan_s) 's Twitter Profile Photo

One of my favorite things about … watching our second year fellows spread their wings exploring what they want to explore while realizing that they’re a part of a bigger community working towards a common goal: curing kidney disease. Pitt Renal

One of my favorite things about #KidneyWk… watching our second year fellows spread their wings exploring what they want to explore while realizing that they’re a part of a bigger community working towards a common goal: curing kidney disease. @PITTRenal
account_circle
Dimerix(@dimerixltd) 's Twitter Profile Photo

Clinical Operations Director Alisha Smith & Chief Medical Officer Dr David Fuller presented a poster of Dimerix’s global Ph3 trial at the American Society of Nephrology conference in Philadelphia last week. is the premier gathering of kidney professionals across the globe.

Clinical Operations Director Alisha Smith & Chief Medical Officer Dr David Fuller presented a poster of Dimerix’s global Ph3 #FSGS trial at the @ASNKidney conference in Philadelphia last week. #KidneyWk is the premier gathering of kidney professionals across the globe.
account_circle